Anti-Histone H3 (acetyl K18) antibody - ChIP Grade
| Name | Anti-Histone H3 (acetyl K18) antibody - ChIP Grade |
|---|---|
| Supplier | Abcam |
| Catalog | ab1191 |
| Prices | $404.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB Array ChIPseq IHC-P ICC/IF ICC/IF ChIP ChIP ChIP |
| Species Reactivities | Mouse, Rat, Bovine, Human, Yeast, Arabidopsis thaliana, Drosophila, Fungi |
| Antigen | Synthetic peptide derived from within residues 1 - 100 Histone H3, acetylated at K18 |
| Blocking Peptide | Human Histone H3 (acetyl K18) peptide |
| Description | Rabbit Polyclonal |
| Gene | HIST1H3A |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
All batches of ab1191 are tested in Peptide Array against peptides to different Histone H3 and H4 modifications. Six dilutions of each peptide are printed on to the Peptide Array in triplicate and results are averaged before being plotted on to a graph. Results show strong binding to Histone H3 - acetyl K18 peptide (ab24003), indicating that this antibody specifically recognises the Histone H3 - acetyl K18 modification.ab17163 - Histone H3 - unmodifiedab16635 - Histone H3 - acetyl K9ab15591 - Histone H3 - acetyl K14ab24003 - Histone H3 - acetyl K18ab48359 - Histone H3 - acetyl K23ab24404 - Histone H3 - acetyl K27ab41409 - Histone H3 - acetyl K36ab15662 - Histone H4 - acetyl K12
Chromatin was prepared from U2OS cells according to the Abcam X-ChIP protocol. Cells were fixed with formaldehyde for 10 min. The ChIP was performed with 25 µg of chromatin, 2 µg of ab1191 (blue), and 20 µl of protein A/G sepharose beads. No antibody was added to the beads control (yellow). The immunoprecipitated DNA was quantified by real time PCR (Taqman approach). Primers and probes are located in the first kb of the transcribed region.
L929, 3T3 and HeLa cells fixed with 2% paraformaldehyde in PBS were incubated for 5 min in 0.2% Triton X-100 in PBS before a blocking step in 5% BSA, 0.1% Tween 20 in PBS (blocking buffer). Ac K18-H3 (ab1191) antibody was added diluted at 1/500 in blocking buffer for a 45 min incubation at room temperature. For visualization, fluorescein isothiocyanate (FITC) anti rabbit secondary antibody was used diluted at 1/800. DAPI (Sigma) in 0.1% Tween 20 in PBS was used in the final washing steps to stain DNA. Vectashield (Vector Laboratories Inc.) was used as mounting medium.The ac K18-H3 antibody revealed a granular staining throughout the nucleoplasm, excluding regions that show an intense DAPI staining (mostly pericentric heterochromatin in mice cells).
Lane 1 : Anti-Histone H3 (acetyl K18) antibody - ChIP Grade (ab1191) at 1 µg/ml (Sample: Histone prep, 0.5 ug/ml )Lane 2 : Anti-Histone H3 (acetyl K18) antibody - ChIP Grade (ab1191) at 1 µg/mlLane 1 : As aboveLane 2 : Human Histone H3 (acetyl K18) peptide (ab24003) at 1 µg/mlSecondaryGoat Anti-Rabbit IgG H&L (HRP) (ab6721) at 1/5000 dilution
ICC/IF image of ab1191 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab1191, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 100% methanol fixed (5 min) Hek293, HepG2 and MCF7 cells at 1µg/ml, and in 4% PFA fixed (10 min) HeLa, Hek293, HepG2 and MCF7 cells at 1µg/ml.
All lanes : Anti-Histone H3 (acetyl K18) antibody - ChIP Grade (ab1191) at 1 µg/mlLane 1 : HeLa Histone Preparation Nuclear LysateLane 2 : HeLa Histone Preparation Nuclear Lysate with Histone H3 peptide - unmodified R17 at 0.5 µg/mlLane 3 : HeLa Histone Preparation Nuclear Lysate with Human Histone H3 (acetyl K9) peptide (ab16635) at 0.5 µg/mlLane 4 : HeLa Histone Preparation Nuclear Lysate with Histone H3 peptide - acetyl K14 at 0.5 µg/mlLane 5 : HeLa Histone Preparation Nuclear Lysate with Human Histone H3 (acetyl K18) peptide (ab24003) at 0.5 µg/mlLane 6 : HeLa Histone Preparation Nuclear Lysate with Human Histone H3 (acetyl K23) peptide (ab48359) at 0.5 µg/mlLane 7 : HeLa Histone Preparation Nuclear Lysate with Human Histone H3 (acetyl K27) peptide (ab24404) at 0.5 µg/mlLane 8 : HeLa Histone Preparation Nuclear Lysate with Histone H3 peptide - acetyl K36 at 0.5 µg/mlLane 9 : HeLa Histone Preparation Nuclear Lysate with Human Histone H4 (acetyl K12) peptide (ab15662) at 0.5 µg/mlLys
IHC image of Histone H3 (acetyl K18) staining in Human normal skin formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab1191, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Product References
Lysine acetyltransferase GCN5b interacts with AP2 factors and is required for - Lysine acetyltransferase GCN5b interacts with AP2 factors and is required for
Wang J, Dixon SE, Ting LM, Liu TK, Jeffers V, Croken MM, Calloway M, Cannella D, Hakimi MA, Kim K, Sullivan WJ Jr. PLoS Pathog. 2014 Jan;10(1):e1003830.
Loss of Drosophila Ataxin-7, a SAGA subunit, reduces H2B ubiquitination and leads - Loss of Drosophila Ataxin-7, a SAGA subunit, reduces H2B ubiquitination and leads
Mohan RD, Dialynas G, Weake VM, Liu J, Martin-Brown S, Florens L, Washburn MP, Workman JL, Abmayr SM. Genes Dev. 2014 Feb 1;28(3):259-72.
Uncoupling transcription from covalent histone modification. - Uncoupling transcription from covalent histone modification.
Zhang H, Gao L, Anandhakumar J, Gross DS. PLoS Genet. 2014 Apr 10;10(4):e1004202.
Potential of adipose-derived mesenchymal stem cells and skeletal muscle-derived - Potential of adipose-derived mesenchymal stem cells and skeletal muscle-derived
Ren Y, Wu H, Ma Y, Yuan J, Liang H, Liu D. PLoS One. 2014 Apr 3;9(4):e93583.
Stat3 promotes IL-10 expression in lupus T cells through trans-activation and - Stat3 promotes IL-10 expression in lupus T cells through trans-activation and
Hedrich CM, Rauen T, Apostolidis SA, Grammatikos AP, Rodriguez Rodriguez N, Ioannidis C, Kyttaris VC, Crispin JC, Tsokos GC. Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13457-62. doi:
Genome-wide and single-cell analyses reveal a context dependent relationship - Genome-wide and single-cell analyses reveal a context dependent relationship
Kasper LH, Qu C, Obenauer JC, McGoldrick DJ, Brindle PK. Nucleic Acids Res. 2014 Oct;42(18):11363-82.
Akt kinase targets the association of CBP with histone H3 to regulate the - Akt kinase targets the association of CBP with histone H3 to regulate the
Liu Y, Xing ZB, Zhang JH, Fang Y. FEBS Lett. 2013 Apr 2;587(7):847-53.
Allele-specific programming of Npy and epigenetic effects of physical activity in - Allele-specific programming of Npy and epigenetic effects of physical activity in
Melas PA, Lennartsson A, Vakifahmetoglu-Norberg H, Wei Y, Aberg E, Werme M, Rogdaki M, Mannervik M, Wegener G, Brene S, Mathe AA, Lavebratt C. Transl Psychiatry. 2013 May 7;3:e255.
Distinct roles of the Gcn5 histone acetyltransferase revealed during transient - Distinct roles of the Gcn5 histone acetyltransferase revealed during transient
Xue-Franzen Y, Henriksson J, Burglin TR, Wright AP. BMC Genomics. 2013 Jul 16;14:479.
A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by - A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by
Schram AW, Baas R, Jansen PW, Riss A, Tora L, Vermeulen M, Timmers HT. PLoS One. 2013 Jul 23;8(7):e70035.